Re: Christian Gratzke, Rob van Maanen, Christopher Chapple, et al. Long-term Safety and Efficacy of Combined Mirabegron and Solifenacin Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.05.005

Publication date: Available online 14 October 2018Source: European UrologyAuthor(s): So-Ryoung Lee, Byoung-Won Park, Jae Heon Kim
Source: European Urology - Category: Urology & Nephrology Source Type: research